Pfizer and Arvinas' experimental treatment significantly extends progression-free survival in breast cancer patients with ...

Sara M. Tolaney, MD, MPH, shares new data from the ASCENT-04 trial of sacituzumab govitecan and pembrolizumab in triple-negative breast cancer.

Trodelvy, in combination with Keytruda, significantly lowers the risk of progression in triple-negative breast cancer by 35%, ...

“The AI test has a negligible failure rate, while current genomic tests have a failure rate of 20% to 30%, necessitating ...

Ahead of National Cancer Survivors Day, ABC 10News anchor Jared Aarons talks with one survivor about her journey and how Scripps Health helped her beat cancer and live a long, fulfilling life.

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...

Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Artificial intelligence (AI)-assisted training improves pathologist accuracy in human epidermal growth factor receptor 2 ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

New AI-driven applications launch seemingly every day, offering endless possibilities. AI can transform our immense body of ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

ASCO 2025 will showcase cutting-edge advancements in precision medicine, artificial intelligence, and biomarker-driven ...